Search

Research

Papua New Guinea (PNG) introduced the 13-valent pneumococcal conjugate vaccine (PCV13) in 2014, with administration at 1, 2, and 3 months of age. PCV13 has reduced or eliminated carriage of vaccine types in populations with low pneumococcal carriage prevalence, carriage density and serotype diversity.

With the help of clinicians and families who have children with Rett syndrome, our research aims to improve understanding of Rett syndrome.

News & Events

This article explores how to support a child's physical and mental health during critical developmental periods, known as the first 1,000 days of life.

Research

Asha Jonathan Bowen Carapetis AM BA MBBS DCH FRACP PhD GAICD FAHMS OAM AM MBBS FRACP FAFPHM PhD FAHMS Head, Healthy Skin and ARF Prevention Executive

News & Events

Impact for Tourette's, the first survey of its kind in Australia provides comprehensive national data on the daily challenges faced by children and adults living with tic-related disorders like Tourette syndrome

Our team aims to optimise lung health early in life to ensure the best possible health outcomes later in life.

Research

We conducted a comprehensive, systematic review of the global childhood population prevalence of impetigo and the broader condition pyoderma.

Learn about our timepoints for online questionnaires and Kids Check Appointments.

Research

Immunomodulatory proteins in human milk (HM) can shape infant immune development. However, strategies to modulate their levels are currently unknown. This study investigated whether maternal prebiotic supplementation alters the levels of immunomodulatory proteins in HM. 

Phage WA have a number of projects underway and these cover a broad range of phage research areas.